Related Experiment Video
Updated: Aug 13, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
A study on comparative efficacyof hypolipidemic drugs
1Department of Basic Medical Sciences, Faculty of Pharmacy, Gomal University, Dera Ismail Khan.
Pakistan Journal of Pharmaceutical Sciences
|January 1, 1995
Summary
Mevacor effectively lowered cholesterol and LDL, while Lopid excelled at managing Triglycerides (TG) and High-density lipoproteins (HDL) in hyperlipidemic patients. Bezalip and Lasona also showed benefits, though Lasona had minimal impact on HDL levels.
Area of Science:
- Cardiology
- Pharmacology
- Metabolic Disorders
Background:
- Hyperlipidemia is a significant risk factor for cardiovascular disease.
- Current treatments aim to manage blood lipid profiles, including cholesterol, LDL, TG, and HDL.
- Comparative efficacy studies are crucial for optimizing therapeutic strategies.
Purpose of the Study:
- To compare the efficacy of four hypolipidemic drugs: Lopid, Mevacor, Bezalip, and Lasona.
- To evaluate their effects on key blood lipid parameters in hyperlipidemic subjects.
- To identify the most potent drug for specific lipid-lowering goals.
Main Methods:
- A study involving sixteen hyperlipidemic subjects previously on Lopid.
- Subjects underwent a washout period before receiving Mevacor, Bezalip, or Lasona for 15 days.
- Blood lipid profiles (cholesterol, LDL, TG, HDL) were analyzed before and after treatment.
Main Results:
- Mevacor demonstrated the highest potency in reducing blood cholesterol and Low-density lipoprotein (LDL).
- Lopid was most effective in maintaining desired levels of Triglycerides (TG) and High-density lipoproteins (HDL).
- Bezalip and Lasona showed significant lipid-modifying effects, with Lasona having a negligible impact on HDL elevation compared to Bezalip.
Conclusions:
- Mevacor is a potent option for lowering cholesterol and LDL.
- Lopid is effective for managing TG and HDL levels.
- Bezalip and Lasona offer alternative hypolipidemic benefits, but their impact on HDL requires consideration.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:06Lipid Digestion
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.